Invion Temettü

Temettü kriter kontrolleri 0/6

Invion does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisin/a
Gelecekteki Temettü Verimin/a
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Ödeme oranın/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Invion Limited's (ASX:IVX) CEO For Now

Nov 22
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Invion Limited's (ASX:IVX) CEO For Now

We Think Invion (ASX:IVX) Can Afford To Drive Business Growth

Jul 07
We Think Invion (ASX:IVX) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Invion's (ASX:IVX) Cash Burn Situation

Mar 24
Here's Why We're Not Too Worried About Invion's (ASX:IVX) Cash Burn Situation

Is Invion (ASX:IVX) In A Good Position To Invest In Growth?

Dec 08
Is Invion (ASX:IVX) In A Good Position To Invest In Growth?

We're Not Very Worried About Invion's (ASX:IVX) Cash Burn Rate

Aug 16
We're Not Very Worried About Invion's (ASX:IVX) Cash Burn Rate

A Look At The Fair Value Of Invion Limited (ASX:IVX)

Nov 04
A Look At The Fair Value Of Invion Limited (ASX:IVX)

Estimating The Intrinsic Value Of Invion Limited (ASX:IVX)

Mar 23
Estimating The Intrinsic Value Of Invion Limited (ASX:IVX)

We Think Invion (ASX:IVX) Can Easily Afford To Drive Business Growth

Nov 26
We Think Invion (ASX:IVX) Can Easily Afford To Drive Business Growth

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if IVX's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if IVX's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Invion Piyasaya Karşı Temettü Getirisi
IVX temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (IVX)n/a
Pazarın Alt %25'i (AU)2.6%
Pazarın En İyi %25'i (AU)6.1%
Sektör Ortalaması (Pharmaceuticals)2.2%
Analist tahmini (IVX) (3 yıla kadar)n/a

Önemli Temettü: Unable to evaluate IVX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate IVX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate IVX's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as IVX has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin